Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation

NCT04357782 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

FED

Sponsor class

Conditions

COVID-19
Hypoxia

Interventions

DRUG: L-ascorbic acid

Sponsor

Hunter Holmes Mcguire Veteran Affairs Medical Center

Collaborators

[object Object]